|
2023
|
Invention
|
Euglobulin-based method for determining the biological activity of defibrotide.
It is disclosed ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of bone diseases and pathologies rel... |
|
|
Invention
|
Cellular-based method for determining the potency of defibrotide.
The present invention relates ... |
|
2022
|
Invention
|
Methods for treating patients having sinusoidal obstruction syndrome.
In various embodiments, th... |
|
2021
|
Invention
|
Euglobulin-based method for determining the biological activity of defibrotide. It is disclosed a... |
|
2020
|
Invention
|
Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
Defibro... |
|
2019
|
Invention
|
Cellular-based method for determining the biological activity of defibrotide.
The present invent... |
|
|
Invention
|
Methods for treating patients having sinusoidal obstruction syndrome. In various embodiments, the... |
|
2018
|
P/S
|
Providing medical information relating to the treatment and
prevention of bone diseases; providi... |
|
|
P/S
|
Providing medical information relating to the treatment and prevention of bone diseases; providin... |
|
2016
|
Invention
|
Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd). Defibrot... |
|
|
P/S
|
Pharmaceutical products, namely, pharmaceutical preparations
for the treatment and prevention of... |
|
|
P/S
|
Pharmaceutical products, namely, pharmaceutical preparations for the treatment and prevention of ... |
|
2015
|
Invention
|
Cellular-based method for determining the biological activity of defibrotide. The present inventi... |
|
|
Invention
|
Cellular-based method for determining the potency of defibrotide. The present invention relates t... |
|
2014
|
Invention
|
Formulation having mobilizing activity. The present innovation relates to a novel formulation cap... |
|
2013
|
Invention
|
Formulations with anti-tumour action.
Formulations with anti-tumour action containing defibrotid... |
|
2011
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of bone diseases; pharmaceutical pre... |
|
|
P/S
|
Pharmaceutical products, pharmaceutical products for the
treatment of pathologies related to the... |
|
|
P/S
|
Pharmaceutical products,Pharmaceutical products for the treatment of pathologies relating to bone... |
|
2010
|
P/S
|
Pharmaceutical and veterinary preparations. |
|
|
Invention
|
Formulation having mobilising activity. The present innovation relates to a novel formulation cap... |
|
2009
|
Invention
|
Synthetic phosphodiester oligonucleotides and therapeutical uses thereof.
A composition of phosp... |
|
|
Invention
|
Synthetic phosphodiester oligonucleotides and therapeutical uses thereof. A composition of phosph... |
|
2008
|
Invention
|
Dna-based aptamers for human cathepsin g. The present research is directed to the identification ... |
|
2006
|
Invention
|
Formulations with anti-tumour action. The use of defibrotide as an anti-tumor agent, alone or in ... |
|
2005
|
Invention
|
Use of sulglicotide for the treatment of mucositis. A method for the treatment and/or prevention ... |
|
2004
|
Invention
|
Method for determining the biological activity of defibrotide. Method for determining the biologi... |
|
2002
|
Invention
|
A method for determining the biological activity of defibrotide. An enzymatic method for determin... |
|
2001
|
P/S
|
Chemicals used in industry, science, photography as well as
in agriculture, horticulture and sil... |
|
|
Invention
|
Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors.... |
|
1999
|
Invention
|
Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments. The inven... |
|
1993
|
P/S
|
Produits chimiques pour l'industrie. Produits pharmaceutiques, produits chimico-pharmaceutiques,
... |
|
1992
|
Invention
|
Hydrolytically processed oligodeoxyribonucleotides and their pharmaceutical compositions. The inv... |
